Oxford Gene Technology Grants Microarray Licence to Febit
News Sep 21, 2005
Oxford Gene Technology (OGT) has announced that it has granted a microarray licence to febit biotech gmbh.
Dr Mike Evans, Chief Executive of OGT, said, “We are happy to support febit biotech’s technology by granting this licence and thus further the use of microarray technology”.
Peer Stähler, CSO of febit biotech gmbh said, “The agreement with OGT strengthens our IP and places us in a position to successfully market Geniom® worldwide”.
The acquired licence refers to the “Southern array patents”, fundamental patents covering the manufacture and use of DNA microarrays, and will remain valid for the patents’ lifetime.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018